Trials / Conditions / KRAS G12S
KRAS G12S
3 registered clinical trials studyying KRAS G12S — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079 | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | Phase 1 |
| Active Not Recruiting | A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors NCT05726864 | Elicio Therapeutics | Phase 1 / Phase 2 |
| Available | Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma NCT07083479 | Elicio Therapeutics | — |